Sarepta Therapeutics: Q1 Earnings Insights

Sarepta Therapeutics SRPT reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Sarepta Therapeutics beat estimated earnings by 55.91%, reporting an EPS of $-0.56 versus an estimate of $-1.27.

Revenue was up $63.90 million from the same period last year.

Last quarter the company beat on EPS by $0.36 which was followed by a 4.66% increase in the share price the next day.

Here's a look at Sarepta Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-1.13	-1.89	-1.29	-1.78
EPS Actual	-0.77	-0.19	-1.52	-1.54
Revenue Estimate	198.61M	173.42M	162.64M	143.33M
Revenue Actual	201.46M	189.41M	164.09M	146.93M

To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar